ReviewPharmacological reports : PR2026
Rifaximin's therapeutic spectrum: approved indications and experimental insights into emerging uses.
Irene Palenca et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it